JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishida, Y.
Right arrow Articles by Kataoka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishida, Y.
Right arrow Articles by Kataoka, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 43, 28019-28024, October 23, 1998


Coiled-coil Interaction of N-terminal 36 Residues of Cyclase-associated Protein with Adenylyl Cyclase Is Sufficient for Its Function in Saccharomyces cerevisiae Ras Pathway*

Yoshimitsu Nishida, Fumi Shima, Hiroyoshi Sen, Yasuhiro Tanaka, Chie Yanagihara, Yuriko Yamawaki-Kataoka, Ken-ichi Kariya, and Tohru KataokaDagger

From the Department of Physiology II, Kobe University School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In the budding yeast Saccharomyces cerevisiae, association with the 70-kDa cyclase-associated protein (CAP) is required for proper response of adenylyl cyclase to Ras proteins. We show here that a small segment comprising the N-terminal 36 amino acid residues of CAP is sufficient for association with adenylyl cyclase as well as for its function in the Ras-adenylyl cyclase pathway as assayed by the ability to confer RAS2Val-19-dependent heat shock sensitivity to yeast cells. The CAP-binding site of adenylyl cyclase was mapped to a segment of 119 amino acid residues near its C terminus. Both of these regions contained tandem repetitions of a heptad motif alpha XXalpha XXX (where alpha  represents a hydrophobic amino acid and X represents any amino acid), suggesting a coiled-coil interaction. When mutants of CAP defective in associating with adenylyl cyclase were isolated by screening of a pool of randomly mutagenized CAP, they were found to carry substitution mutations in one of the key hydrophobic residues in the heptad repeats. Furthermore, mutations of the key hydrophobic residues in the heptad repeats of adenylyl cyclase also resulted in loss of association with CAP. These results indicate the coiled-coil mechanism as a basis of the CAP-adenylyl cyclase interaction.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The budding yeast Saccharomyces cerevisiae has two RAS genes, RAS1 and RAS2, whose protein products are structurally, functionally, and biochemically similar to mammalian Ras proto-oncoproteins (for reviews, see Refs. 1 and 2). The yeast Ras proteins are essential regulatory elements of adenylyl cyclase, which catalyzes the production of cAMP, a second messenger vital for cell growth (3, 4). The Ras-adenylyl cyclase pathway has been implicated in transduction of a signal triggered by glucose to an intracellular environment where a protein phosphorylation cascade is induced by cAMP. Yeast cells bearing the activated RAS2 gene, RAS2Val-19, exhibit an elevated level of intracellular cAMP and display abnormal phenotypes, including sensitivity to heat shock, sensitivity to nutritional starvation, and failure to sporulate (3, 5).

Yeast adenylyl cyclase, encoded by the CYR1 gene, consists of 2026-amino acid residues that comprise at least four domains: the N-terminal, the middle leucine-rich repeat, the catalytic, and the C-terminal domains (6, 7). The leucine-rich repeat domain contains a binding site for Ras proteins (8, 9). Adenylyl cyclase forms a complex with 70-kDa CAP.1 CAP was identified biochemically as the only protein associated tightly with adenylyl cyclase and also by genetic screening of a gene whose mutation abolished the RAS2Val-19-dependent heat shock sensitivity (10, 11). Studies on the function of CAP revealed that CAP is a multifunctional protein. It was shown that the N-terminal region, mapped to residues 1-168, is required for acquisition of heat shock sensitivity in the RAS2Val-19 background while the C-terminal region, mapped to residues 369-526, is required for normal cell morphology and responsiveness to nutrient deprivation and excess (12). The C-terminal function appears to be related to regulation of the actin cytoskeleton as evidenced by complementation of its defect by overexpression of profilin or SNC1 (13, 14) and by demonstration of its direct association with actin monomer and of its actin-sequestering activity (15, 16). In addition, CAP possesses two proline-rich sequences in its middle region intervening between the two regions, with which associations of actin-binding protein 1, elongation factor 1alpha , and ribosomal protein L3 were recently shown (17, 18).

The N-terminal region of CAP binds to the C-terminal region of adenylyl cyclase (19), and this association appears to be required for the proper in vivo response of adenylyl cyclase to Ras, because its loss by mutation of either CAP or adenylyl cyclase resulted in disappearance of the RAS2Val-19-dependent heat shock sensitivity and in a reduced cAMP response to glucose stimulation (19). This function resides solely in the CAP N-terminal region and is separable from the functions of the other regions as reported (12). We have recently shown biochemically that the association of adenylyl cyclase with the CAP N-terminal region is responsible for efficient stimulation of adenylyl cyclase activity by the posttranslationally modified form of Ras, although the molecular mechanism underlying this process remains to be clarified (20). In this report, we have mapped a minimal region of CAP responsible for its N-terminal function and analyzed the molecular mechanism for its association with adenylyl cyclase.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cell Strains and Growth Media-- The S. cerevisiae strains used are listed in Table I. Replacement of the chromosomal CAP gene with its N-terminal deletion mutant CAPDelta N-1 was carried out as described previously (20). The resulting yeast strain expresses only the C-terminal segment of CAP corresponding to residues 369-526 under control of the yeast ADC1 promoter. Yeast cells were grown in YPD (2% Bacto-peptone, 1% Bacto-yeast extract, 2% glucose) or yeast synthetic medium (0.67% yeast nitrogen base, 2% glucose) with appropriate auxotrophic supplements. Genetic manipulations of yeast cells were performed as described previously (21). Transformation into yeast cells was carried out with lithium acetate (22).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Yeast strains used in this study

Construction of Expression Plasmids and Oligonucleotide-directed Mutagenesis-- A plasmid, pAD-GST-CAP (18), was used to express the full-length CAP in yeast as a fusion protein with GST under control of the ADC1 promoter. Various deletions were introduced into the CAP gene by cleavage of pAD-GST-CAP with suitable pairs of restriction endonucleases and resealing by T4 DNA ligase with a linker oligonucleotide, 5'-CTAGTCTAGACTAG-3', bearing stop codons in all reading frames, between. The resulting plasmids were designated as pAD-GST-CAP-(x-x)s, where x-x represents the range of the expressed CAP polypeptides in amino acid positions. A 5'-terminal 107-base pair fragment corresponding to residues 1-36 of CAP, CAP-(1-36), was amplified by PCR (23) using suitable oligonucleotide primers and, after cleavage with BamHI and SmaI in the primer sequences, cloned into pAD-GST to produce pAD-GST-CAP-(1-36). Similarly, DNA fragments encoding various C-terminal polypeptides of adenylyl cyclase were amplified by PCR using suitable primers and cloned into pAD-GST to produce pAD-GST-CYR1-(y-y), where y-y represented the range of the expressed adenylyl cyclase polypeptide in amino acid positions. Specific amino acid substitution mutations were introduced into adenylyl cyclase by the gapped duplex method using suitable mutagenic oligonucleotides (24). The mutant genes were used to replace the corresponding wild-type genes in the expression plasmids. YEP24-ADC1-CYR1-(1-40, 1769-2026) and YEP24-ADC1-CYR1-(1-40, 606-2026), which expressed adenylyl cyclase carrying internal deletions of residues 41-1768 and 41-605, were identical to YEP24-ADC1-CYR1-(Delta 41-1768) and YEP24-ADC1-CYR1-(Delta 41-605), respectively, described previously (8, 19).

Yeast Two-hybrid Assay-- The various mutant CAP genes were transferred to pGBT9 or pGBT10 vector (25) for expression of the corresponding polypeptides as GBT fusions in yeast. Similarly, the various mutant CYR1 genes were transferred to pGAD-GH (25) for expression as GAD fusions. The resulting plasmids were designated as pGBT-CAP-(x-x) or pGAD-CYR1-(y-y), respectively. The reporter yeast strain YPB2(CAPDelta N) was cotransformed with pGAD-CYR1-(y-y) and pGBT-CAP-(x-x), and the resulting Trp+, Leu+-transformants were assayed for beta -galactosidase activity by a filter assay as described (25).

Random Mutagenesis of CAP-- A DNA fragment corresponding to CAP-(1-77), was subjected to an error-prone PCR to introduce random mutations as described before (26). The amplified fragments were cleaved with BamHI and SmaI present in the PCR primers, cloned into matching cleavage sites of pGBT10, and examined for interaction with pGAD-CYR1-(1879-2026) by the yeast two-hybrid assay as described above. The CAP mutants that failed to interact with CYR1(1879-2026) were characterized by DNA sequencing and transferred to pAD-GST for expression as GST-fusion proteins in yeast cells.

Measurement of in Vivo Association between CAP and Adenylyl Cyclase-- Yeast FS1 was transformed with a combination of either YEP24-ADC1-CYR1-(1-40, 1769-2026) or YEP24-ADC1-CYR1-(1-40, 606-2026) and one of the pAD-GST-CAP-(x-x) plasmids bearing various mutations. In another series of experiments, SP1 was transformed with pAD-GST-CYR1-(y-y) bearing various mutations. The resulting transformants were grown to a density of 1 × 107 cells/ml, harvested by centrifugation, and disrupted by shaking with glass beads in buffer C (50 mM MES, pH 6.2, 0.1 mM MgCl2, 0.1 mM EGTA, 2 mM dithiothreitol, 10% glycerol) as described previously (9, 19). Crude membrane fraction was prepared by centrifugation of the homogenate at 27,000 × g for 80 min. GST-CAP-(x-x) or GST-CYR1-(y-y) protein was solubilized from the crude membrane fraction with buffer C containing 1% Lubrol PX, 0.5 M NaCl, and 1 mM phenylmethylsulfonyl fluoride, adsorbed onto glutathione-Sepharose resin, and eluted with 20 mM glutathione as described (27). Proteins bound to the GST-fusion proteins, which were co-eluted from the resin, were subjected to Western immunoblot detection of CYR1 or CAP by using specific antibodies: rabbit polyclonal antisera for a 15-amino acid synthetic peptide of the C terminus of adenylyl cyclase (anti-CYR1CT) or for the full-length CAP (anti-CAP), respectively, as described previously (19). A rabbit polyclonal antiserum for GST (anti-GST) was used for detection of GST fusion proteins.

Other Methods-- Survival of yeast cells after heat shock treatment at 55 °C for 5 min was examined by a replica plating method as described previously (3, 19). SDS-polyacrylamide gel electrophoresis and Western immunoblot analysis were performed as described (28, 29). The ECL immunodetection system (Amersham Pharmacia Biotech) was used for signal development.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Mapping of the Mutual Binding Sites of CAP and Adenylyl Cyclase-- Previous experiments had already mapped the N-terminal function of CAP to residues 1-168 (12) and the CAP-binding site of adenylyl cyclase to residues 1879-2026 (19). To further delineate the binding sites, we introduced various deletion mutations into CAP and adenylyl cyclase as described under "Experimental Procedures." Interactions of the various CAP mutants with CYR1-(1879-2026) and of the various CYR1 C-terminal mutants with CAP were examined by employing the yeast two-hybrid system (Fig. 1A). As an indicator strain, we used YPB2(CAPDelta N), whose chromosomal CAP gene was replaced by its N-terminal deletion mutant CAPDelta N-1 in order to exclude the possibility that endogenous CAP complexed with an otherwise negative GAD-fusion CAP mutant may serve as a bridge to yield a positive interaction with the GBT-fusion CYR1. Formation of such a CAP dimer had been reported before (16). To our surprise, the shortest CAP construct carrying only the N-terminal 36 residues, CAP-(1-36), as well as the longer CAP-(1-66), CAP-(1-77), and CAP-(1-88) exhibited a positive interaction with the C-terminal region of adenylyl cyclase (Fig. 1A). In contrast, CAP-(78-526) lacking the N-terminal region did not exhibit any interaction. On the other hand, the shortest fragment of CYR1 giving a positive interaction with CAP was 119 residues corresponding to positions 1898-2016 (Fig. 1A). An N-terminal deletion up to position 1935 destroyed the activity to interact with CAP.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   Yeast two-hybrid and in vivo binding analyses of the interaction between yeast adenylyl cyclase and CAP. A, the indicated combinations of pGBT-CAP-(x-x) and pGAD-CYR1-(y-y) were transformed into the reporter yeast strain YPB2(CAPDelta N), and two independent isolates of the resulting transformants were assayed for beta -galactosidase activity by a filter assay as described under "Experimental Procedures." B, CYR1-(1-40, 1769-2026) protein copurified with various GST-CAP-(x-x) from the membrane extracts of FS1 cells expressing them was separated by SDS-polyacrylamide gel electrophoresis (10% gel) and detected by Western immunoblotting with anti-CYR1CT antibody as described under "Experimental Procedures" (lower part). GST-CAP-(x-x) proteins eluted from glutathione-Sepharose resin were detected by immunoblotting with anti-GST antibody (upper part). The molecular size markers indicated were Escherichia coli maltose-binding protein-fusion paramyosin (83 kDa), bovine liver glutamic dehydrogenase (62 kDa), rabbit muscle aldolase (47 kDa), and rabbit muscle triosephosphate isomerase (32 kDa). C, the endogenous CAP copurified with GST-CYR1-(y-y) proteins from SP1 cells was separated by SDS-polyacrylamide gel electrophoresis (10% gel) and detected by Western immunoblotting with anti-CAP antibody (lower part). GST-CYR1(y-y) proteins eluted from glutathione-Sepharose resin were detected by immunoblotting with anti-GST antibody (upper part). Equivalent results were obtained in three independent experiments.

Physical associations of the same sets of CAP and CYR1 mutants with their counterparts were also examined biochemically as shown in Fig. 1, B and C. The CAP deletion mutants were expressed as GST fusions from pAD-GST-CAP-(x-x)s in yeast FS1 cells harboring YEP24-ADC1-CYR1-(1-40, 1769-2026). The GST-CAP fusion proteins were purified by glutathione-Sepharose chromatography and examined for the bound CYR1-(1-40, 1769-2026) by immunoblotting with anti-CYR1CT antibody (Fig. 1B). Similarly, proteins copurified with GST-CYR1-(y-y)s from yeast cells harboring pAD-GST-CYR1-(y-y)s were examined for CAP by anti-CAP antibody (Fig. 1C). The results were in good agreement with those of the yeast two-hybrid analysis; the shortest CAP and CYR1 fragments that retained the activity to associate with their counterparts were CAP-(1-36) and CYR1-(1898-2016), respectively. These results indicated that residues 1-36 of CAP and residues 1898-2016 of adenylyl cyclase are sufficient for their mutual association.

CAP-(1-36) Is Sufficient for Its N-terminal Function in Vivo-- We examined the abilities of the CAP deletion mutants to confer heat shock sensitivity to TK161-R2V(CAPDelta N) cells, which carried the CAPDelta N-1 gene encoding the protein lacking its N-terminal function and thereby were made resistant to heat shock in the RAS2Val-19 background. As shown in Fig. 2A, expression of the shortest fragment, GST-CAP-(1-36), as well as other longer CAP N-terminal fragments was sufficient to restore the heat shock sensitivity in this yeast strain. As observed in the binding assays, both GST-CAP-(77-526) and GST only were found inactive. This result implied that the N-terminal 36 residues are functional in the Ras-adenylyl cyclase pathway.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 2.   Heat shock sensitivity of yeast cells carrying various deletion mutants of CAP or CYR1. A, two independent isolates of TK161-R2V(CAPDelta N) yeast cells harboring pAD-GST (Vector) or pAD-GST-CAP carrying the indicated CAP fragments were examined for heat shock sensitivity by the replica plating method as described under "Experimental Procedures." Shown are photographs of the two replica plates, one subjected to 55 °C heat shock for 5 min (left part) and the other without the heat shock treatment (right part), after 2 days of growth at 30 °C. B, two independent isolates of TK161-R2V yeast cells harboring pAD-GST (Vector) or pAD-GST-CYR1 carrying the indicated CYR1 C-terminal fragments were examined for heat shock sensitivity as described for A. The experiments were repeated three times, yielding identical results.

Heat shock sensitivity was also used for examining the CAP binding activity of various CYR1 fragments. It had been shown that overexpression of the CAP-binding region of adenylyl cyclase suppressed the RAS2Val-19-dependent heat shock sensitivity presumably by competitive sequestration of CAP from the endogenous adenylyl cyclase (19). We examined the activity of the CYR1-deletion mutants overexpressed from pAD-GST-CYR1-(y-y) to suppress the heat shock sensitivity of TK161-R2V (Fig. 2B). Again, the result was in good agreement with that of the CAP-binding assays, i.e. CYR1-(1898-2016) was the shortest fragment exhibiting this activity.

Identification of Mutations That Abrogate the CAP-Adenylyl Cyclase Interaction-- The mutually interacting regions, CAP-(1-36) and CYR1-(1898-2016), were searched for a peculiar sequence motif hinting at the mechanism of their interaction. The search identified tandem repetitions of a heptad motif alpha XXalpha XXX (where alpha  and X represent a hydrophobic amino acid and any amino acid, respectively; for reviews, see Refs. 30 and 31) in both residues 13-30 of CAP and residues 1916-1930 of adenylyl cyclase (Fig. 3A). If the heptad repeat motif is taken as that of a leucine zipper LXXXXXX (32), adenylyl cyclase has one more repeat unit in residues 1931-1937. These heptad repeats enabled us to predict formation of alpha -helices that are wound around each other to form a superhelix, the coiled-coil structure (30, 31). This was also supported by calculation of the probability of adopting a coiled-coil conformation using the computer program COILS (33). Residues 11-33 of CAP were predicted to have more than 95% probability of forming a coiled-coil, whereas the probability for the other portion of CAP was almost 0. 


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Structures of the mutually interacting regions of CAP and adenylyl cyclase. A, the amino acid sequences corresponding to CAP-(1-36) and CYR1-(1898-2016) are shown by one-letter amino acid codes. Hydrophobic residues in the typical heptad repeats are represented by boldface type. B, spinning wheel representations of the two possibly interacting segments CAP-(6-34) and CYR1-(1916-1940). The residues of CAP and adenylyl cyclase whose mutations abolished the CAP-cyclase interaction are shown in boldface type. The residues occupying positions a and d are supposed to make an interphase between the two alpha  helices, although it is presently unclear how the two strands make a pair with each other to form a coiled-coil superhelix as discussed under "Discussion."

To further analyze the molecular mechanism for the CAP-adenylyl cyclase interaction, we introduced random mutations into residues 1-77 of CAP by an error-prone PCR and carried out a yeast two-hybrid screening for mutants that became defective in associating with adenylyl cyclase as described under "Experimental Procedures." Out of 208 clones analyzed, 43 showed up negative in interacting with CYR1-(1879-2026) and were subjected to DNA sequencing to identify the nature of mutations. 33 clones carrying a stop codon or more than two mutations within residues 1-36 were discarded, and CAP-(1-77) inserts of the remaining 10 clones, whose mutations are shown in Table II, were transferred to pAD-GST for expression as GST-fusion proteins in the yeast FS-1. GST-CAP-(1-77) proteins derived from all 10 clones were expressed in a similar amount and solubilizable from the membranes by Lubrol PX, but those from five clones (HS92, HS113, HS143, HS155, and HS197) were found to have lost the ability to attach onto glutathione-Sepharose resin (data not shown), suggesting gross alterations in their conformations, and, therefore, were excluded from further analyses. The remaining five clones were examined for physical association with a deletion mutant CYR1 protein that retained the Ras-responsive adenylyl cyclase activity (8) (Fig. 4A). The results clearly indicated that GST-CAP-(1-77) from the five clones HS10, HS27, HS139, HS205, and HS208 lost the ability to associate with CYR1-(1-40, 606-2026). Concurrently, the same CAP mutants lost the activity to confer heat shock sensitivity to TK161-R2V(CAPDelta N) yeast cells (Fig. 5A). Strikingly, four out of the five clones turned out to carry an amino acid substitution mutation at Leu-20, Leu-27, or Val-30, all of which corresponded to the key hydrophobic residues in the heptad repeats (Fig. 3A). Moreover, the mutations were introduced in such a way that the hydrophobic residues were converted to neutral or hydrophilic residues (Table II). The other clone HS205 carried two mutations, T31P and Q34L. Although Gln-34 is located at the position in the heptad repeats corresponding to the key hydrophobic residue, it is presently unclear which of the two mutations is responsible for the effect.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Amino acid substitutions found in CAP mutants


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of mutations on the CAP-adenylyl cyclase interaction. A, copurification of CYR1-(1-40, 606-2026) protein with GST-CAP-(1-77) protein carrying wild-type sequence (WT) or the indicated CAP mutants (see Table II) was examined as described in the legend to Fig. 1B. The bound CYR1-(1-40, 606-2026) protein was detected by immunoblotting with anti-CYR1CT antibody (bottom), while GST-CAP(1-77) and its mutants were detected with anti-GST antibody (top). The molecular size markers were identical to those used in Fig. 1B except for inclusion of E. coli maltose-binding protein fusion beta -galactosidase (172 kDa). B, interaction of CYR1-(1879-2026) protein and those carrying the indicated mutations with CAP-(1-66) was examined by the yeast two-hybrid method as described in the legend to Fig. 1A. C, copurification of the endogenous CAP with GST-CYR1-(1898-2016) protein (WT) or that carrying the indicated mutation was examined as described in the legend to Fig. 1C. CAP was detected by immunoblotting with anti-CAP antibody (bottom). GST-CYR1-(1898-2016) and its mutants were detected by immunoblotting with anti-GST antibody (top). Equivalent results were obtained in at least two independent experiments.


View larger version (90K):
[in this window]
[in a new window]
 
Fig. 5.   Heat shock sensitivity of yeast cells expressing the mutated CAP and adenylyl cyclase. A, heat shock sensitivity of TK161-R2V(CAPDelta N) yeast cells harboring pAD-GST (Vector), pAD-GST-CAP-(1-77) (Wild type), or pAD-GST-CAP-(1-77) carrying the indicated mutation was examined as described in the legend to Fig. 2A. B, heat shock sensitivity of TK161-R2V cells harboring pAD-GST (Vector), pAD-GST-CYR1-(1822-2026) (Wild type), or pAD-GST-CYR1-(1822-2026) carrying the indicated mutation was examined similarly. The experiments were repeated three times, yielding identical results.

Next, we examined the importance of hydrophobic residues in the predicted heptad repeats of adenylyl cyclase in association with CAP. The key hydrophobic residues Leu-1916 and Leu-1923 corresponding to the alpha -position (Fig. 3A) were converted to Ser and to either Pro or Arg, respectively, by oligonucleotide-directed mutagenesis. The CYR1 C-terminal fragments carrying L1916S, L1923P, and L1923R mutations all lost the ability to associate with CAP as assayed by the yeast two-hybrid method (Fig. 4B) or by the in vivo binding assay (Fig. 4C). Overexpression of CYR1-(1822-2026) bearing the same mutations could not suppress the RAS2Val-19-dependent heat shock sensitivity (Fig. 5B). These results indicated that the hydrophobic residues of both CAP and adenylyl cyclase are indeed critical not only for their mutual association but also for their proper function in the Ras-adenylyl cyclase pathway and further supported the involvement of the coiled-coil mechanism for their interaction.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We have shown that the N-terminal 36 residues of CAP are sufficient for association with adenylyl cyclase as well as for its in vivo function in the Ras-adenylyl cyclase pathway. The CAP-binding site of adenylyl cyclase was mapped to a 119-residue segment near the C terminus. Close inspection of the primary sequences of the two mutual binding sites has identified typical heptad repeat motifs (alpha XXalpha XXX)n indicative of a coiled-coil interaction (30, 31) (Fig. 3A). Furthermore, the presence of the coiled-coil in the CAP N terminus was predicted by the computer program COILS (33). Coiled-coils are composed of two, three, or four alpha -helices wound around each other to form a left-handed superhelix. This structure is found in a wide variety of proteins including cytoskeletal structural proteins, transcription factors, etc. (30, 31). Further, a number of proteins whose three-dimensional structures have been determined are found to contain coiled-coil segments, many of them very short. The presence of this structure in a protein can be predicted from an array of the typical heptad motif in its amino acid sequence, which is labeled a-b-c-d-e-f-g, where a and d are primarily hydrophobic, most frequently Leu, residues and form the helix interface, while b, c, e, f, and g are hydrophilic and form the solvent-exposed surface of the coiled-coil. The association of the helices is stabilized by hydrophobic interactions at the side chains of the hydrophobic residues a and d, which form an apolar stripe along one side of the helix, and additionally by ionic interactions at the side chains of the nearby charged residues. This is apparent in spinning wheel representations of the two possibly interacting segments CAP-(6-34) and CYR1-(1916-1940) (Fig. 3B). The assignments of the a- and d-positions were supported by an amino acid sequence homology between CAP-(6-34) and Dirofilaria immitis paramyosin (34), which was found by BLASTP search (35) of GenBankTM entries. Residues 16-29 of CAP (Fig. 3A) shared nine identical residues with residues 213-226 of paramyosin (LAQQLEEARRRLED). This match made it possible to predict positions a-g of each residue of CAP from the proposed alpha -helical structure of paramyosin (36).

A further proof for the coiled-coil interaction came from the studies on mutations of CAP and adenylyl cyclase, which abrogated the interaction. Strikingly, the three residues of CAP (Leu-20, Leu-27, and Val-30) and two residues of adenylyl cyclase (Leu-1916 and Leu-1923) that were identified to be essential for the interaction based on these mutational studies are all hydrophobic and located at position a or d. These results strongly support the notion that the coiled-coil mechanism forms a molecular basis for the CAP-adenylyl cyclase interaction.

At present, it is impossible for us to predict from the amino acid sequences how many strands of CAP and adenylyl cyclase contribute to the formation of the coiled-coil superhelix. It is also impossible to predict the relative orientation, parallel or anti-parallel, of the strands of CAP and adenylyl cyclase and how individual pairs of the residues from each strand are formed, both of which are primarily determined by polar and ionic interactions between residues flanking the hydrophobic core (30, 31). Elucidation of these structural features awaits determination of the three-dimensional structure of the CAP-adenylyl cyclase complex.

The heptad repeat structure is well conserved in CAP homologues identified in other organisms including Schizosaccharomyces pombe and mammals, although the N-terminal function of the budding yeast CAP is not conserved among them (37-40). This suggests that in those organisms CAP may establish a coiled-coil interaction at its N-terminal short segment with a certain protein to exert a function that is presumably different from that of the Ras-adenylyl cyclase pathway. The identification of such a CAP-interacting protein may reveal a novel function of CAP in addition to its C-terminal cytoskeletal function, which is known to be conserved between yeasts and mammals (37-40).

    ACKNOWLEDGEMENTS

We thank X.-H. Deng for skillful technical assistance and A. Seki and A. Kawabe for help in preparation of this manuscript.

    FOOTNOTES

* This investigation was supported by Grants-in-Aid for Scientific Research on Priority Areas and for Scientific Research (B) from the Ministry of Education, Science, Sports and Culture of Japan and by a grant from the Yamanouchi Foundation for Research on Metabolic Disease.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 81-78-341-7451 (ext. 3230); Fax: 81-78-341-3837; E-mail: kataoka{at}kobe-u.ac.jp.

The abbreviations used are: CAP, adenylyl cyclase-associated protein; CYR1, adenylyl cyclase; GST, glutathione S-transferasePCR, polymerase chain reactionGBT, GAL4 DNA-binding domainGAD, GAL4 transactivation domainMES, 2-(N-morpholino)ethanesulfonic acid.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Broach, J. R., and Deschenes, R. J. (1990) Adv. Cancer Res. 54, 79-139[Medline] [Order article via Infotrieve]
  2. Gibbs, J. B., and Marshall, M. (1989) Microbiol. Rev. 53, 171-185[Abstract/Free Full Text]
  3. Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T., Broek, D., Cameron, S., Broach, J., Matsumoto, K., and Wigler, M. (1985) Cell 40, 27-36[CrossRef][Medline] [Order article via Infotrieve]
  4. Broek, D., Samiy, N., Fasano, O., Fujiyama, A., Tamanoi, F., Northup, J., and Wigler, M. (1985) Cell 41, 763-769[CrossRef][Medline] [Order article via Infotrieve]
  5. Kataoka, T., Powers, S., McGill, C., Fasano, O., Strathern, J., Broach, J., and Wigler, M. (1984) Cell 37, 437-445[CrossRef][Medline] [Order article via Infotrieve]
  6. Kataoka, T., Broek, D., and Wigler, M. (1985) Cell 43, 493-505[CrossRef][Medline] [Order article via Infotrieve]
  7. Yamawaki-Kataoka, Y., Tamaoki, T., Choe, H.-R., Tanaka, H., and Kataoka, T. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 5693-5697[Abstract/Free Full Text]
  8. Suzuki, N., Choe, H.-R., Nishida, Y., Yamawaki-Kataoka, Y., Ohnishi, S., Tamaoki, T., and Kataoka, T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 8711-8715[Abstract/Free Full Text]
  9. Minato, T., Wang, J., Akasaka, K., Okada, T., Suzuki, N., and Kataoka, T. (1994) J. Biol. Chem. 269, 20845-20851[Abstract/Free Full Text]
  10. Field, J., Vojtek, A., Ballester, R., Bolger, G., Colicelli, J., Ferguson, K., Gerst, J., Kataoka, T., Michaeli, T., Powers, S., Riggs, M., Rodgers, L., Wieland, I., Wheland, B., and Wigler, M. (1990) Cell 61, 319-327[CrossRef][Medline] [Order article via Infotrieve]
  11. Fedor-Chaiken, M., Deschenes, R. J., and Broach, J. R. (1990) Cell 61, 329-340[CrossRef][Medline] [Order article via Infotrieve]
  12. Gerst, J. E., Ferguson, K., Vojtek, A., Wigler, M., and Field, J. (1991) Mol. Cell. Biol. 11, 1248-1257[Abstract/Free Full Text]
  13. Vojtek, A. B., Harrer, B., Field, J., Gerst, J., Pollard, T. D., Brown, S., and Wigler, M. (1991) Cell 66, 497-505[CrossRef][Medline] [Order article via Infotrieve]
  14. Gerst, J. E., Rodgers, L., Riggs, M., and Wigler, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4338-4342[Abstract/Free Full Text]
  15. Freeman, L. N., Chen, Z., Horenstein, J., Weber, A., and Field, J. (1995) J. Biol. Chem. 270, 5680-5685[Abstract/Free Full Text]
  16. Zelicof, A., Protopopov, V., David, D., Lin, X.-Y., Lustgarten, V., and Gerst, J. E. (1996) J. Biol. Chem. 271, 18243-18252[Abstract/Free Full Text]
  17. Freeman, L. N., Lila, T., Mintzer, A. K., Chen, A. K., Pahk, J. A., Ren, R., Drubin, G. D., and Field, J. (1996) Mol. Cell. Biol. 16, 548-556[Abstract]
  18. Yanagihara, C., Shinkai, M., Kariya, K., Yamawaki-Kataoka, Y., Hu, C.-D., Masuda, T., and Kataoka, T. (1997) Biochem. Biophys. Res. Commun. 232, 503-507[CrossRef][Medline] [Order article via Infotrieve]
  19. Wang, J., Suzuki, N., Nishida, Y., and Kataoka, T. (1993) Mol. Cell. Biol. 13, 4087-4097[Abstract/Free Full Text]
  20. Shima, F., Yamawaki-Kataoka, Y., Yanagihara, C., Tamada, M., Okada, T., Kariya, K., and Kataoka, T. (1997) Mol. Cell. Biol. 17, 1057-1064[Abstract]
  21. Rose, M. D., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics: A Laboratory Course Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  22. Ito, H., Fukuda, Y., Murata, K., and Kimura, A. (1983) J. Bacteriol. 153, 163-168[Abstract/Free Full Text]
  23. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Arnheim, N. (1985) Science 230, 1350-1354[Abstract/Free Full Text]
  24. Kramer, W., and Fritz, H.-J. (1987) Methods Enzymol. 154, 350-367[Medline] [Order article via Infotrieve]
  25. Bartel, P. L., Chien, C.-T., Sternglanz, R., and Fields, S. (1993) in Cellular Interactions in Development: A Practical Approach (Hartley, D. A., ed), pp. 153-179, Oxford University Press, Oxford
  26. Gram, H., Marconi, L.-A., Barbas, C. F., III, Collet, T. A., Lerner, R. A., and Kang, A. S. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3576-3580[Abstract/Free Full Text]
  27. Smith, D. B., and Johnson, K. S. (1988) Gene (Amst.) 67, 31-40[CrossRef][Medline] [Order article via Infotrieve]
  28. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
  29. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract/Free Full Text]
  30. Cohen, C., and Parry, D. A. D. (1986) Trends Biochem. Sci. 11, 245-248[CrossRef]
  31. Lupas, A. (1996) Trends Biochem. Sci. 21, 375-382[CrossRef][Medline] [Order article via Infotrieve]
  32. Landschultz, W. H., Johnson, P. F., and McKnight, S. L. (1988) Science 240, 1759-1764[Abstract/Free Full Text]
  33. Lupas, A. (1996) Methods Enzymol. 266, 513-525[Medline] [Order article via Infotrieve]
  34. Limberger, R. J., and McReynolds, L. A. (1990) Mol. Biochem. Parasitol. 38, 271-280[CrossRef][Medline] [Order article via Infotrieve]
  35. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410[CrossRef][Medline] [Order article via Infotrieve]
  36. McLachlan, A. D., and Karn, J. (1982) Nature 299, 226-231[CrossRef][Medline] [Order article via Infotrieve]
  37. Kawamukai, M., Gerst, J., Field, J., Riggs, M., Rodgers, L., Wigler, M., and Young, D. (1992) Mol. Biol. Cell 3, 167-180[Abstract]
  38. Matviw, H., Yu, G., and Young, D. (1992) Mol. Cell. Biol. 12, 5033-5040[Abstract/Free Full Text]
  39. Zelicof, A., Gatica, J., and Gerst, J. E. (1993) J. Biol. Chem. 268, 13448-13453[Abstract/Free Full Text]
  40. Vojtek, A. B., and Cooper, J. A. (1993) J. Cell Sci. 105, 777-785[Abstract]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
G. M. Santangelo
Glucose Signaling in Saccharomyces cerevisiae
Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 253 - 282.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
Y.-S. Bahn, J. K. Hicks, S. S. Giles, G. M. Cox, and J. Heitman
Adenylyl Cyclase-Associated Protein Aca1 Regulates Virulence and Differentiation of Cryptococcus neoformans via the Cyclic AMP-Protein Kinase A Cascade
Eukaryot. Cell, December 1, 2004; 3(6): 1476 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. A. Noegel, R. Blau-Wasser, H. Sultana, R. Muller, L. Israel, M. Schleicher, H. Patel, and C. J. Weijer
The Cyclase-associated Protein CAP as Regulator of Cell Polarity and cAMP Signaling in Dictyostelium
Mol. Biol. Cell, February 1, 2004; 15(2): 934 - 945.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
C. Dubacq, R. Guerois, R. Courbeyrette, K. Kitagawa, and C. Mann
Sgt1p Contributes to Cyclic AMP Pathway Activity and Physically Interacts with the Adenylyl Cyclase Cyr1p/Cdc35p in Budding Yeast
Eukaryot. Cell, August 1, 2002; 1(4): 568 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. Moriyama and I. Yahara
Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover
J. Cell Sci., April 15, 2002; 115(8): 1591 - 1601.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. V. HUBBERSTEY and E. P. MOTTILLO
Cyclase-associated proteins: CAPacity for linking signal transduction and actin polymerization
FASEB J, April 1, 2002; 16(6): 487 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kido, F. Shima, T. Satoh, T. Asato, K.-i. Kariya, and T. Kataoka
Critical Function of the Ras-associating Domain as a Primary Ras-binding Site for Regulation of Saccharomyces cerevisiae Adenylyl Cyclase
J. Biol. Chem., January 25, 2002; 277(5): 3117 - 3123.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Shima, T. Okada, M. Kido, H. Sen, Y. Tanaka, M. Tamada, C.-D. Hu, Y. Yamawaki-Kataoka, K.-i. Kariya, and T. Kataoka
Association of Yeast Adenylyl Cyclase with Cyclase-Associated Protein CAP Forms a Second Ras-Binding Site Which Mediates Its Ras-Dependent Activation
Mol. Cell. Biol., January 1, 2000; 20(1): 26 - 33.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Yu, C. Wang, S. J. Palmieri, B. K. Haarer, and J. Field
A Cytoskeletal Localizing Domain in the Cyclase-associated Protein, CAP/Srv2p, Regulates Access to a Distant SH3-binding Site
J. Biol. Chem., July 9, 1999; 274(28): 19985 - 19991.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Noegel, F Rivero, R Albrecht, K. Janssen, J Kohler, C. Parent, and M Schleicher
Assessing the role of the ASP56/CAP homologue of Dictyostelium discoideum and the requirements for subcellular localization
J. Cell Sci., January 10, 1999; 112(19): 3195 - 3203.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishida, Y.
Right arrow Articles by Kataoka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishida, Y.
Right arrow Articles by Kataoka, T.
Social Bookmarking